US › Healthcare

Health Catalyst Inc (HCAT)

US · Healthcare · Health Information Services

$2.28+3.17%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$70.8M
Revenue YoY
-10.9%
Net profit
$-111.0M
Profit YoY
-367.6%
EPS
$0.02
EPS estimate
$0.01
Net margin
-156.9%

EPS came in at 0.02 against a street estimate of 0.01 — a beat of 100.0%.

Key statistics

Market cap
$163.3M
Forward P/E
7.8
P/B
1.11
Book value
$1.87
EPS (TTM)
$-3.73
52-week high
$3.88
52-week low
$0.96
50-day MA
$1.87
200-day MA
$2.01
Beta
1.56

Analyst view

Analysts rate Health Catalyst Inc a buy (9 buy, 4 hold, 0 sell out of 13) with an average price target of $2.25.

Shareholding

Insiders
5.48%
Institutions
77.77%

Largest institutional holders

FundStake
First Light Asset Management, LLC17.43%
CDC Financial, Inc.8.54%
BlackRock Inc6.95%
Vanguard Group Inc6.00%
Whetstone Capital Advisors, LLC5.78%
Nepsis, Inc.4.03%
Palogic Value Management LP3.92%
Vanguard Capital Management, LLC3.91%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Health Catalyst Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.